In Thursday's meeting, the director of the FDA's Center for Drug Evaluation and Research said plans for coming layoffs were ...
Many Americans have started to question the quality of ingredients used within their food, some of which are banned in Europe ...
Traditionally the recommendations have been voted on by an advisory committee, but the agency made the decision on its own ...
The U.S. Food and Drug Administration told staff this week it cannot guarantee work space or parking spots among the hurdles ...
It’s time to revamp the FDA’s “generally recognized as safe,” or GRAS, program that allows companies to add untested ...
It's marketed as a generic option to name-brand mood meds, but it's been recalled for the same reason a competitor was just ...
The Senate Health, Education, Labor, and Pensions Committee approved Dr. Jayanta Bhattacharya’s nomination to be NIH director ...
The U.S. Food and Drug Administration said on Monday it will not take action against compounding pharmacies making copies of ...
Health and Human Services Secretary Robert F. Kennedy Jr. ordered the Food and Drug Administration on Monday to revise its ...
US Health and Human Services secretary Robert F. Kennedy Jr. directs the Food and Drug Administration to explore revamping ...
The FDA says state-licensed compounding pharmacies must immediately stop making compound versions of GLP-1 drugs. Larger, national licensed facilities making compound versions of Zepbound have until ...
The Food and Drug Administration said several lots of six products containing benzoyl peroxide are being recalled, including ...